dc.contributor.author |
Feyerabend, Susan |
de_DE |
dc.date.accessioned |
2014-08-07T11:13:49Z |
|
dc.date.available |
2014-08-07T11:13:49Z |
|
dc.date.issued |
2014 |
de_DE |
dc.identifier.issn |
1464-4096 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/55397 |
|
dc.language.iso |
en |
en |
dc.publisher |
Wiley - Blackwell |
de_DE |
dc.relation.uri |
https://doi.org/10.1111/bju.12437 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05) |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140610213910_00643 |
de_DE |
utue.publikation.seiten |
429-436 |
de_DE |
utue.personen.roh |
Krege, Susanne |
de_DE |
utue.personen.roh |
Rexer, Heidrun |
de_DE |
utue.personen.roh |
vom Dorp, Frank |
de_DE |
utue.personen.roh |
de Geeter, Patrick |
de_DE |
utue.personen.roh |
Klotz, Theodor |
de_DE |
utue.personen.roh |
Retz, Margitte |
de_DE |
utue.personen.roh |
Heidenreich, Axel |
de_DE |
utue.personen.roh |
Kuehn, Michael |
de_DE |
utue.personen.roh |
Kamradt, Joern |
de_DE |
utue.personen.roh |
Feyerabend, Susan |
de_DE |
utue.personen.roh |
Wuelfing, Christian |
de_DE |
utue.personen.roh |
Zastrow, Stefan |
de_DE |
utue.personen.roh |
Albers, Peter |
de_DE |
utue.personen.roh |
Hakenberg, Oliver |
de_DE |
utue.personen.roh |
Roigas, Jan |
de_DE |
utue.personen.roh |
Fenner, Martin |
de_DE |
utue.personen.roh |
Heinzer, Hans |
de_DE |
utue.personen.roh |
Schrader, Mark |
de_DE |
dcterms.isPartOf.ZSTitelID |
Bju International |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
113 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |